{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:42:08Z","timestamp":1783129328975,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402733 \/ 2016 \\u2013 9"],"award-info":[{"award-number":["402733 \/ 2016 \\u2013 9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["402733\/2016?"],"award-info":[{"award-number":["402733\/2016?"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009730","name":"Universidade Federal de Ouro Preto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ - 00851"],"award-info":[{"award-number":["APQ - 00851"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejps.2020.105382","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T20:30:58Z","timestamp":1590525058000},"page":"105382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nanoemulsion composed of 10-(4,5-dihydrothiazol-2-yl)thio)decan-1-ol), a synthetic analog of 3-alkylpiridine marine alkaloid: development, characterization, and antimalarial activity"],"prefix":"10.1016","volume":"151","author":[{"given":"Marina Goulart Da","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Ferreira","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Bar\u00e7ante","family":"Perasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Tupinamb\u00e1","family":"Branquinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Silva","family":"Mour\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harley Da Silva","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Costa Trench","family":"Xocaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Silqueira Martins","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-7486","authenticated-orcid":false,"given":"Gustavo Henrique Ribeiro","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2939-7780","authenticated-orcid":false,"given":"Fernando De Pilla","family":"Varotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-3521","authenticated-orcid":false,"given":"Gisele Rodrigues Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105382_bib0001","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11095-010-0309-1","article-title":"Nano-emulsions and Micro-emulsions: clarifications of the critical differences","volume":"28","author":"Anton","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105382_bib0002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2017.11.006","article-title":"Synthesis and evaluation of the mutagenicity of 3-alkylpyridine marine alkaloid analogues with anticancer potential","volume":"825","author":"Barbosa","year":"2018","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"431","key":"10.1016\/j.ejps.2020.105382_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2011.12.031","article-title":"Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies","volume":"15","author":"Borhade","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2020.105382_bib0004","first-page":"943","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay - assessment of radiosensitivity","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2020.105382_bib0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuropharm.2015.08.043","article-title":"Lipid nanocapsules containing the non-ionic surfactant Solutol HS 15 inhibit the transport of calcium through hyper for inactivated channels in neuronal cells","volume":"99","author":"Chauvet","year":"2015","journal-title":"Neuropharmacl"},{"key":"10.1016\/j.ejps.2020.105382_bib0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mib.2018.09.003","article-title":"Rodent malaria models: insights into human disease and parasite biology","volume":"46","author":"De Niz","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2020.105382_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2017.11.002","article-title":"Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model","volume":"123","author":"Dawre","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"126","key":"10.1016\/j.ejps.2020.105382_bib0008","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.colsurfb.2014.12.052","article-title":"Arteether nanoemulsion for enhanced efficacy against plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability","volume":"1","author":"Dwivedi","year":"2015","journal-title":"Colloids Surf. B Biointerfaces."},{"issue":"1","key":"10.1016\/j.ejps.2020.105382_bib0009","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial Polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2020.105382_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0020-7519(96)00152-X","article-title":"Quinoline antimalarials: mechanisms of action and resistance","volume":"27","author":"Foley","year":"1997","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2020.105382_bib0011","series-title":"Drug and the Pharmaceutical Science","first-page":"412","article-title":"Pharmaceutical emulsions, double emulsion and microemulsion","author":"Garti","year":"1996"},{"issue":"138","key":"10.1016\/j.ejps.2020.105382_bib0012","article-title":"Improvement of antimalarial activity of a 3-alkylpiridine alkaloid analog by replacing the pyridine ring to a thiazole-containing heterocycle: mode of action, mutagenicity profile, and Caco-2 cell-based permeability","volume":"1","author":"Guimar\u00e3es","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105382_bib0013","unstructured":"International Conference on Harmonization \u2013 ICH - Topic Q 1 A (R2)Stability testing of new drug substances and products. 2003. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.pdf."},{"issue":"11","key":"10.1016\/j.ejps.2020.105382_bib0014","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2020.105382_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11101-012-9249-1","article-title":"The Arctic sponge Haliclona viscosa as a source of a wide array of 3-alkyl pyridine alkaloids","volume":"12","author":"K\u00f6ck","year":"2013","journal-title":"Phytochem. Ver."},{"issue":"3","key":"10.1016\/j.ejps.2020.105382_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejps.2020.105382_bib0017","series-title":"Encyclopedia of Pharmaceutical Technology: vol. 1","first-page":"4117","article-title":"Zeta potential","author":"Li","year":"1992"},{"issue":"556","key":"10.1016\/j.ejps.2020.105382_bib0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2018.11.073","article-title":"Nanoformulation of curcumin-loaded eudragit-nutriosomes to counteract malaria infection by a dual strategy: improving antioxidant intestinal activity and systemic efficacy","volume":"10","author":"Manconi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105382_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115608","article-title":"Amphotericin B-loaded Eudragit RLl100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis","volume":"230","author":"Melo","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2020.105382_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4922(03)00028-X","article-title":"Malaria drug-sensitivity testing: new assays, new perspectives","volume":"19","author":"Noedl","year":"2003","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.ejps.2020.105382_bib0021","first-page":"104","article-title":"Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin. artif. cells nanomed","volume":"47","author":"Nosrati","year":"2019","journal-title":"Biotechnol"},{"issue":"9","key":"10.1016\/j.ejps.2020.105382_bib0022","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C7MD00637C","article-title":"Recent updates in the discovery and development of novel antimalarial drug candidates","volume":"1","author":"Okombo","year":"2018","journal-title":"Medchemcomm"},{"issue":"3","key":"10.1016\/j.ejps.2020.105382_bib0023","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.nano.2015.11.017","article-title":"Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles","volume":"12","author":"Omwoyo","year":"2016","journal-title":"Nanomed. Nanotechnol."},{"issue":"7","key":"10.1016\/j.ejps.2020.105382_bib0024","first-page":"4046","article-title":"Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and In Vitro assays. antimicrob. agents","volume":"59","author":"Parapini","year":"2015","journal-title":"Chemother"},{"issue":"5","key":"10.1016\/j.ejps.2020.105382_bib0025","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1039\/C5FO01517K","article-title":"The influence of droplet size on the stability, in vivo digestion, and oral bioavailability of vitamin E emulsions","volume":"7","author":"Parthasarathi","year":"2016","journal-title":"Food Funct."},{"issue":"22","key":"10.1016\/j.ejps.2020.105382_bib0026","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejps.2020.105382_bib0027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-4894(65)90012-3","article-title":"Drug resistance in plasmodium berghei vincke and lips, 1948. I. chloroquine resistance","volume":"17","author":"Peters","year":"1965","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejps.2020.105382_bib0028","unstructured":"Pharmaceutical Technology Institute \u2013 Farmanguinhos \u2013 Oswaldo Cruz Foundation \u2013 Fiocruz \u2013 Chloroquine Diphosphate - DMG-FAR-PRO-CLO-000-2017. 2017. https:\/\/www.far.fiocruz.br\/wp-content\/uploads\/2017\/02\/Cloroquina-ProfSaude.pdf."},{"issue":"18","key":"10.1016\/j.ejps.2020.105382_bib0029","first-page":"447","article-title":"In vivo compartmental kinetics of Plasmodium falciparum histidine-rich protein II in the blood of humans and in BALB\/c mice infected with a transgenic Plasmodium berghei parasite expressing histidine-rich protein II","volume":"30","author":"Poti","year":"2019","journal-title":"Malar. J"},{"issue":"511","key":"10.1016\/j.ejps.2020.105382_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2016.07.021","article-title":"Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: enhanced efficacy at reduced dose and dosing frequency","volume":"10","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105382_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molliq.2015.11.050","article-title":"Critical steps and energetics involved in a successful development of a stable nanoemulsion","volume":"214","author":"Qadir","year":"2016","journal-title":"J. Mol. Liq."},{"issue":"56","key":"10.1016\/j.ejps.2020.105382_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/acs.jcim.5b00742","article-title":"Revealing the binding process of new 3-alkylpyridine marine alkaloid analogue antimalarials and the heme group: an experimental and theoretical investigation","volume":"28","author":"Ribeiro-Viana","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2020.105382_bib0033","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2014","journal-title":"J. Med. Chem."},{"issue":"347","key":"10.1016\/j.ejps.2020.105382_bib0034","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"22","author":"Singh","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.ejps.2020.105382_bib0035","first-page":"203","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol","volume":"57","author":"Slater","year":"1993","journal-title":"Therapeut"},{"key":"10.1016\/j.ejps.2020.105382_bib0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.exppara.2010.01.028","article-title":"Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design","volume":"126","author":"Taylor-Robinson","year":"2010","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.ejps.2020.105382_bib0037","first-page":"149","article-title":"Development insights of surface modified lipid nanoemulsions of dihydroartemisinin for malaria chemotherapy: characterization, and in vivo antimalarial evaluation. Recent pat","volume":"13","author":"Umeyor","year":"2019","journal-title":"Biotechnol"},{"issue":"375","key":"10.1016\/j.ejps.2020.105382_bib0038","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa1602250","article-title":"Antimalarial activity of KAF156 in falciparum and Vivax malaria","volume":"22","author":"White","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2020.105382_bib0039","article-title":"Malaria eradication: benefits, future scenarios and feasibility","year":"2019","journal-title":"Executive summ."},{"key":"10.1016\/j.ejps.2020.105382_bib0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.powtec.2009.09.004","article-title":"Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology","volume":"103","author":"Zhang","year":"2010","journal-title":"Powder Technol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:44Z","timestamp":1778558204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720301718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":40,"alternative-id":["S0928098720301718"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105382","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoemulsion composed of 10-(4,5-dihydrothiazol-2-yl)thio)decan-1-ol), a synthetic analog of 3-alkylpiridine marine alkaloid: development, characterization, and antimalarial activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105382"}}